Navigation Links
Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
Date:9/24/2007

ter syndrome in the U.S., Europe, and Canada, among other regions. In addition, REPLAGAL(TM), for the treatment of Fabry disease, which is available in Europe and other regions outside of the US, continues to perform well.

"Shire HGT is well-positioned for sustained growth, with a strong portfolio and pipeline offering a range of potential therapies for patients suffering from genetic diseases," said Sylvie Gregoire, President of Shire HGT. "Elaprase has been successfully launched globally, Replagal continues to perform well and we have some exciting opportunities in our early pipeline as well as in our business development prospects. I am very excited about this new opportunity and look forward to working with a team of professionals dedicated to addressing the needs of patients with genetic diseases, and leading our business through its next phase of development."

Sylvie most recently served as Chairwoman of the Board for IDM Pharma. Prior to IDM Pharma, she was President & Chief Executive Officer of GlycoFi(TM), Inc. (acquired by Merck & Co. in May 2006), a biotechnology company developing biologics independently and with partners. Prior to this, Sylvie was EVP of Technical Operations and a member of the management team at Biogen. She also held various senior clinical and regulatory affairs roles at Merck & Co. in the US and abroad. In addition to serving on the Board of Directors for IDM Pharma, Thallion Pharmaceuticals and Cubist Pharmaceuticals, she was recently appointed to the Board of Directors of the Greater Boston Food Bank. She is also on the Board of Trustees at the International School of Boston. Sylvie received her Doctor of Pharmacy degree from the State University of New York at Buffalo and her pharmacy graduate degree from the Universite Laval in Quebec City, Canada.

Notes to editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the sp
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 The announced sales of three healthcare ... looking to expand in non-healthcare areas, says Kalorama Information. ... research firm says that  Siemens is the third largest ... of the IVD market , with 5.5 billion in ... composition would likely affect IVD market shares.  ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 On January, ... the Baltimore and Washington D.C. science community to the ... The event, sponsored by the Protein Society, will take ... University Center, Room 312. Through discussion, presentations and ... structural importance of proteins, their role in the industry ...
(Date:11/26/2014)... November 25, 2014 Whitehouse Laboratories ... joined the Morris County (New Jersey) Chamber of ... a leading business organization in the North Jersey ... further engage some key clients in the pharmaceutical ... the geographic area. Membership enables Whitehouse Laboratories a ...
(Date:11/26/2014)... November 25, 2014 Continuing its award-winning ... earned three prestigious MarCom Awards for outstanding creative achievement ... a Platinum MarCom Award, the organization’s top honor, in ... St. Louis held in April of this year. The ... 14,000 attendees. Additionally, Nerium was awarded a Gold MarCom ...
Breaking Biology Technology:Kalorama: Sale of Three Siemens Healthcare Units Raises Questions About Firm's IVD Future 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2
... New Analysis of the 104 ABPM Study Presented at the American Heart ... Association ... http://www.nicox.com , ... a new analysis of the data,from the 104 Ambulatory Blood Pressure Monitoring (ABPM) study ...
... "Horror In The Wind," has been banned by Allen Theaters of ... screen the locally produced comedy because it is too political. ... reverses the whole world,s sexual orientation. , ... Alamogordo, ...
... LOUIS, Nov. 11 At the Board of ... cash dividend of,$.13 per share. The dividend is ... on December 1, 2008., About Sigma-Aldrich: Sigma-Aldrich ... Our biochemical and organic chemical products and kits,are ...
Cached Biology Technology:NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen 2NicOx' Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen 3Comedy 'Horror In The Wind' Banned In New Mexico 2Comedy 'Horror In The Wind' Banned In New Mexico 3
(Date:11/3/2014)... Researchers from Australia report that low birth weight and ... (OA)-related hip replacements in adulthood. Findings published in the ... & Research , indicate that low birth weight and ... arthroplasty due to OA as adults. , According ... of 25 are diagnosed with clinical OA. Symptoms of ...
(Date:11/2/2014)... November 2014)—In support of a bold quest to rid ... Gates Foundation today announced an award of US$156 million ... (MVI) in building new vaccines that will interrupt the ... "accelerating to zero" agenda. Such vaccines would ensure that ... called an "immunological bed net." , This approach ...
(Date:11/2/2014)... Nate Silver and Richard Feynman walk into a bar and ... may sound like the setup to some late-night nerd sketch, ... increasingly cumbersome problem in modern biology, namely, finding meaning in ... instance, the data comprisesreams of cancer mutations that genome-wide studies ... new and efficient ways to parse the signal from the ...
Breaking Biology News(10 mins):Preterm, low birth-weight babies may need new hips in adulthood 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Mutant models 2Mutant models 3Mutant models 4
... thousands of years on tiny islands surrounding Australia have evolved ... their mainland cousins. Now, new research in The American ... driven by the need to have big-mouthed babies. Mainland ... cm) long, patrol swampy areas in search of frogs, their ...
... PORTLAND, Ore. (May 15, 2012)Twenty-six scientists have received a ... Psoriasis Foundation to study psoriasisthe most common autoimmune disease ... Americansand psoriatic arthritis, an inflammatory joint and tendon disease. ... $50,000 Discovery Grant, for a total of $400,000, for ...
... in gardens, burned for heat and energy, and converted into ... that includes corn, sorghum and sugarcane. Two new, independently produced ... that likely is a parent of Miscanthus giganteus , ... M. sinensis genome. The studies reveal how a ...
Cached Biology News:Big-mouthed babies drove the evolution of giant island snakes 2Big-mouthed babies drove the evolution of giant island snakes 3National Psoriasis Foundation awards more than $2 million for research 2Maps of Miscanthus genome offer insight into grass evolution 2Maps of Miscanthus genome offer insight into grass evolution 3
Immunogen: Extract of pigmented melanoma metastases from lymph nodes. Storage: -20 C, Avoid Freeze/Thaw Cycles...
with GlutaMAXIL-glutamine...
alpha N-catenin (C-19)...
This STAT antibody sampler pack contains 8 monoclonal ,STAT antibodies....
Biology Products: